Alieu Amara

1.1k total citations
36 papers, 637 citations indexed

About

Alieu Amara is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Alieu Amara has authored 36 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 14 papers in Virology and 10 papers in Epidemiology. Recurrent topics in Alieu Amara's work include HIV/AIDS drug development and treatment (25 papers), HIV Research and Treatment (14 papers) and HIV/AIDS Research and Interventions (10 papers). Alieu Amara is often cited by papers focused on HIV/AIDS drug development and treatment (25 papers), HIV Research and Treatment (14 papers) and HIV/AIDS Research and Interventions (10 papers). Alieu Amara collaborates with scholars based in United Kingdom, Nigeria and Uganda. Alieu Amara's co-authors include Saye Khoo, Laura Else, David Back, Marta Boffito, Adeniyi Olagunju, Sujan Dilly Penchala, Andrew Owen, Catriona Waitt, Michael Morris and Marco Siccardi and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Clinical Chemistry.

In The Last Decade

Alieu Amara

35 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alieu Amara United Kingdom 17 379 172 117 94 90 36 637
J Biollaz Switzerland 14 263 0.7× 130 0.8× 157 1.3× 94 1.0× 145 1.6× 16 769
Sheila Breidinger United States 14 466 1.2× 311 1.8× 79 0.7× 140 1.5× 128 1.4× 23 697
Peter Langmann Germany 15 348 0.9× 199 1.2× 151 1.3× 68 0.7× 60 0.7× 37 555
Rosa F. Yeh United States 12 348 0.9× 166 1.0× 135 1.2× 105 1.1× 85 0.9× 25 682
Aurélie Barrail‐Tran France 16 387 1.0× 194 1.1× 112 1.0× 83 0.9× 75 0.8× 35 639
Neil Buss Switzerland 13 375 1.0× 252 1.5× 130 1.1× 90 1.0× 98 1.1× 17 655
Alexandre Béguin Switzerland 11 237 0.6× 140 0.8× 68 0.6× 73 0.8× 105 1.2× 12 522
Marie‐Claude Gagnieu France 19 278 0.7× 71 0.4× 273 2.3× 102 1.1× 169 1.9× 63 889
Daniel Röshammar Sweden 12 264 0.7× 149 0.9× 77 0.7× 72 0.8× 53 0.6× 22 564
Rajith K. R. Rajoli United Kingdom 15 230 0.6× 119 0.7× 39 0.3× 87 0.9× 87 1.0× 29 493

Countries citing papers authored by Alieu Amara

Since Specialization
Citations

This map shows the geographic impact of Alieu Amara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alieu Amara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alieu Amara more than expected).

Fields of papers citing papers by Alieu Amara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alieu Amara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alieu Amara. The network helps show where Alieu Amara may publish in the future.

Co-authorship network of co-authors of Alieu Amara

This figure shows the co-authorship network connecting the top 25 collaborators of Alieu Amara. A scholar is included among the top collaborators of Alieu Amara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alieu Amara. Alieu Amara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fitzgerald, Richard J., Laura Dickinson, Laura Else, et al.. (2022). Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Clinical Infectious Diseases. 75(1). e525–e528. 14 indexed citations
2.
Herrera, Carolina, Julianne Lwanga, Ming Lee, et al.. (2021). Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP). Journal of Antimicrobial Chemotherapy. 76(8). 2129–2136. 9 indexed citations
3.
Amara, Alieu, Sujan Dilly Penchala, Laura Else, et al.. (2021). The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva. Journal of Pharmaceutical and Biomedical Analysis. 206. 114356–114356. 61 indexed citations
4.
Harvala, Heli, Claire Reynolds, Samreen Ijaz, et al.. (2021). Evidence of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) among blood donors: a pilot study, England June 2018 to July 2019. Sexually Transmitted Infections. 98(2). 132–135. 12 indexed citations
6.
Cerrone, Maddalena, Laura Else, Alieu Amara, et al.. (2018). Pharmacokinetics of dolutegravir with and without darunavir/cobicistat in healthy volunteers. Journal of Antimicrobial Chemotherapy. 74(1). 149–156. 8 indexed citations
7.
Waitt, Catriona, Adeniyi Olagunju, Alieu Amara, et al.. (2017). Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC–MS/MS. Journal of Chromatography B. 1060. 300–307. 27 indexed citations
8.
Amara, Alieu, Nicole Pagani, Laura Else, et al.. (2017). Once-daily atazanavir/cobicistat and darunavir/cobicistat exposure over 72 h post-dose in plasma, urine and saliva: contribution to drug pharmacokinetic knowledge. Journal of Antimicrobial Chemotherapy. 72(7). 2035–2041. 6 indexed citations
9.
Penchala, Sujan Dilly, Laura Else, Deirdre Egan, et al.. (2016). The development and application of a novel LC–MS/MS method for the measurement of Dolutegravir, Elvitegravir and Cobicistat in human plasma. Journal of Chromatography B. 1027. 174–180. 29 indexed citations
10.
Moltó, José, Cristina Miranda, Saye Khoo, et al.. (2016). Removal of Dolutegravir by Hemodialysis in HIV-Infected Patients with End-Stage Renal Disease. Antimicrobial Agents and Chemotherapy. 60(4). 2564–2566. 13 indexed citations
11.
Olagunju, Adeniyi, Oluseye O. Bolaji, Alieu Amara, et al.. (2015). Breast Milk Pharmacokinetics of Efavirenz and Breastfed Infants' Exposure in Genetically Defined Subgroups of Mother-Infant Pairs: An Observational Study. Clinical Infectious Diseases. 61(3). 453–463. 30 indexed citations
12.
Amara, Alieu, Akil Jackson, Graeme Moyle, et al.. (2015). Dolutegravir and elvitegravir plasma concentrations following cessation of drug intake. Journal of Antimicrobial Chemotherapy. 71(4). 1031–1036. 24 indexed citations
13.
Dickinson, Laura, H. Manisha Yapa, Akil Jackson, et al.. (2015). Plasma Tenofovir, Emtricitabine, and Rilpivirine and Intracellular Tenofovir Diphosphate and Emtricitabine Triphosphate Pharmacokinetics following Drug Intake Cessation. Antimicrobial Agents and Chemotherapy. 59(10). 6080–6086. 19 indexed citations
14.
Olagunju, Adeniyi, Alieu Amara, Catriona Waitt, et al.. (2015). Validation and clinical application of a method to quantify nevirapine in dried blood spots and dried breast-milk spots. Journal of Antimicrobial Chemotherapy. 70(10). 2816–2822. 22 indexed citations
15.
Olagunju, Adeniyi, Marco Siccardi, Alieu Amara, et al.. (2014). CYP2B6 516G>T (rs3745274) and Smoking Status Are Associated With Efavirenz Plasma Concentration in a Serbian Cohort of HIV Patients. Therapeutic Drug Monitoring. 36(6). 734–738. 8 indexed citations
16.
Amara, Alieu, Laura Else, John Tjia, et al.. (2014). A Validated Method for Quantification of Efavirenz in Dried Blood Spots Using High-Performance Liquid Chromatography–Mass Spectrometry. Therapeutic Drug Monitoring. 37(2). 220–228. 25 indexed citations
17.
Else, Laura, Akil Jackson, Rebekah Puls, et al.. (2011). Pharmacokinetics of Lamivudine and Lamivudine-Triphosphate after Administration of 300 Milligrams and 150 Milligrams Once Daily to Healthy Volunteers: Results of the ENCORE 2 Study. Antimicrobial Agents and Chemotherapy. 56(3). 1427–1433. 28 indexed citations
18.
McArdle, F., et al.. (2007). Albumin overload induces adaptive responses in human proximal tubular cells through oxidative stress but not via angiotensin II type 1 receptor. American Journal of Physiology-Renal Physiology. 292(6). F1846–F1857. 26 indexed citations
19.
Bone, J. M., Alieu Amara, Alan Shenkin, et al.. (2004). Calcineurin Inhibitors and Proximal Renal Tubular Injury in Renal Transplant Patients with Proteinuria and Chronic Allograft Nephropathy. Transplantation. 79(1). 119–122. 12 indexed citations
20.
Rustom, Rana, Robert A. Sells, Alieu Amara, et al.. (2001). RENAL TUBULAR PEPTIDE CATABOLISM IN CHRONIC VASCULAR REJECTION. Renal Failure. 23(3-4). 517–531. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026